CN1105721C - 麻醉性镇痛剂的制备 - Google Patents

麻醉性镇痛剂的制备 Download PDF

Info

Publication number
CN1105721C
CN1105721C CN97198338A CN97198338A CN1105721C CN 1105721 C CN1105721 C CN 1105721C CN 97198338 A CN97198338 A CN 97198338A CN 97198338 A CN97198338 A CN 97198338A CN 1105721 C CN1105721 C CN 1105721C
Authority
CN
China
Prior art keywords
methyl
represent hydrogen
hydrogen
alcohol
rhodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN97198338A
Other languages
English (en)
Other versions
CN1231667A (zh
Inventor
B·穆德赖克
J·坎特
C·萨皮诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson Matthey PLC
Original Assignee
Johnson Matthey PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey PLC filed Critical Johnson Matthey PLC
Publication of CN1231667A publication Critical patent/CN1231667A/zh
Application granted granted Critical
Publication of CN1105721C publication Critical patent/CN1105721C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

本发明公开了一种采用催化量的均相有机金属配合物制备诸如二氢可待因酮和二氢吗啡酮之类麻醉镇痛药的新方法。

Description

麻醉性镇痛剂的制备
本发明涉及利用催化量的均相有机金属配合物制备诸如二氢可待因酮和二氢吗啡酮之类麻醉性镇痛剂的新方法。
二氢可待因酮和二氢吗啡酮都是半合成的阿片类(opioid)镇痛剂，它们具有与可待因和吗啡类似性质的多种作用，包括对中枢神经系统和平滑肌的作用。这些阿片剂的确切作用机理尚不清楚，但据信与中枢神经系统中的阿片受体有关。
过去已经存在多种制备二氢可待因酮和二氢吗啡酮的方法，这些方法包括氢化可待因酮( Arch.Pharm.(1920)， 258，295)、氧化二氢可待因(DE 415097；US 2715626)、氧化二氢吗啡( 有机化学杂志(J.Org.Chem.)(1950) 15，1103，US 2628962；US 2654756；US2649454)、电解还原吗啡( 日本药物科学杂志(J.Pharm.Soc.Japan)(1936)， 56，44和(1942)，62，347)或催化重排可待因或吗啡(DE623821， 应用放射性同位素(App.Radiat.Isot.)(1987) 38，651)。但所有这些方法都是高成本低效率的两步法。
采用钯黑催化重排吗啡的方法已有记载。但是，这种方法除得到所需产物外，还得到30-35％不希望的O-脱甲基蒂巴因酮，因而这一方法不可能以适合生产的大规模方式进行。而且纯净产物的分离过程也十分冗长，并需要广泛提纯。
本发明人现已发现一种新的一步法制备二氢可待因酮和二氢吗啡酮的方法，其产率大于80％，而且纯化也只需通过简单方法极简单地进行。
因此，本发明提供了制备式(I)化合物的新方法：
Figure C9719833800041
其中R1代表氢，甲基或通常用于保护酚和醇的保护基；R2代表氢，甲基，烯丙基，环丁基甲基，苄基，三烷基甲硅烷基或胺保护基；R3代表氢，羟基或氨基；该方法包括使式(I I)化合物：其中R1，R2和R3的定义同上，与式(III)有机金属配合物反应：
Figure C9719833800052
其中M代表金属；Ar各自代表芳基或环乙基，n代表2-5，X代表BF4 -或ClO4 -，且solv代表甲醇，二氯甲烷/甲醇，四氢呋喃或乙醇。
R1定义内的醇或酚保护基的实例包括醚(如甲氧基甲基、苄氧基甲基、2-(三甲基甲硅烷基)-乙氧基甲基醚、四氢吡喃基、苯甲酰甲基、烯丙基、三乙基甲硅烷基、叔丁基二甲基甲硅烷基)，酯(例如乙酸酯、新戊酸酯(pivaloate)、苯甲酸酯)，碳酸酯(例如苄基、甲基)和磺酸酯(例如甲磺酸酯，甲苯磺酸酯)。
R2定义内的胺保护基的实例包括氨基甲酸酯(例如甲基、2，2，2-三氯乙基、2-甲基甲硅烷基、三乙基甲硅烷基、叔丁基、苄基)，酰胺(例如甲酰基、乙酰基、苯甲酰基、环丁基)，磺酸酯和氨基乙醛缩衍生物。
适宜的R1为氢或甲基。
适宜的R2为氢或甲基，优选氢。
适宜的R3为氢。
适宜的M为铑，钯，铂，铱或铁，优选铑。
适宜的Ar为苯基或环己基基团，优选Ar为苯基。
优选n为4。
反应适宜在极性溶剂或溶剂混合物中进行，例如甲醇，甲醇/二氯甲烷，四氢呋喃，丙酮或乙醇。优选反应在甲醇/二氯甲烷混合物中进行。
反应适宜在5℃-50℃的非极限温度下进行。优选反应在室温(例如25℃-27℃)的温度下进行。
式(II)化合物为市售品，式(III)化合物则可以采用Bosnich等在 美国化学会会志(J.Am.Chem.Soc.)(1991)， 113，958和 有 机金属(Organometallics)(1988)， 7，936中所述的类似方法通过有机金属化合物与式(IV)化合物反应而制得：
Figure C9719833800061
本发明在此通过实施例加以说明，但本发明并不局限于此。
                      实施例1
              大规模制备二氢可待因酮
将配有机械搅拌器、通气管、排气管和温度计的2升四颈圆底烧瓶用氮气冲洗，加入无水甲醇(500ml)。向溶剂中鼓氮气脱氧10-15分钟。然后在氮气氛下加入四氟硼酸双(二环[2.2.1]庚-2，5-二烯)合铑(I)(1.88g，0.005M)和1，4-双(二苯膦基)丁烷(2.17g，0.0051M)，在室温下搅拌所得溶液30分钟。通氢气氢化溶液30分钟，此时溶液的颜色从橙色变为褐黄。
向溶液中鼓氮气10分钟以除去过量氢气，接着在氮气流及搅拌下向溶液中加入可待因(150g，0.5M)。搅拌反应混合物5-15分钟，二氢可待因酮开始以细微结晶形式沉淀析出。加入二氯甲烷(300ml)以溶解所有固体。搅拌暗红色均匀溶液1小时。反应完成之后，在室温下真空浓缩溶液至大约其原始体积的一半。滤出沉淀出的产物，在滤器上用冷甲醇(100ml)浆化，再用甲醇(1×100ml)洗涤，在60-70℃下真空干燥16小时后，得到124.5g(83％)二氢可待因酮游离碱。1H NMR(CDCl3)：δ1.26(qd，J＝4.3Hz和13.0Hz，1H)；1.75-1.90(m，2H)；2.06(td，J＝4.6Hz和12.0Hz，1H)；2.20(td，J＝3.4Hz和12.0Hz，1H)；2.30(dd，J＝6.0Hz和18.5Hz，1H)；2.36(td，J＝4.7Hz和13.7Hz，1H)；2.38-2.48(m，1H)；2.43(s，3H)；2.51-2.61(m，2H)；3.03(d，J＝18.5Hz，1H)；3.17(dd，J＝2.8和5.4Hz，1H)；3.91(s，3H)；4.65(s，1H)；6.63(d，J＝8.2Hz，1H)；6.70(d，J＝8.2Hz，1H).
13C NMR(CDCl3)：δ19.8；25.5；35.3；40.0；42.4；42.7；46.58；46.65；56.6：58.9；91.2；114.5；119.5；126.2；127.2；142.5；145.2；207.5.
                   实施例2
               制备二氢吗啡酮
将配有磁力搅拌器、气体入口管、排气管和温度计的100ml三颈圆底烧瓶用氮气冲洗，尔后加入无水甲醇(10ml)和二氯甲烷(5ml)。向溶剂中鼓入干燥氮气脱氧10分钟。然后在氮气氛下加入四氟硼酸双(二环[2.2.1]庚-2，5-二烯)合铑(I)(112mg，0.0003M)和1，4-双(二苯膦基)丁烷(130mg，0.00031M)，在室温下搅拌所得溶液15分钟。接着通氢气氢化溶液10分钟，向溶液中鼓入氮气5分钟以除去过量氢气.温热催化剂溶液到40℃，在缓和氮气流下加入吗啡(2.14g，0.0075M)。将暗黑色溶液在40℃搅拌4小时。粗制物的1H NMR表明存在88％二氢吗啡酮，8％未反应的吗啡和3-4％未确定的副产物。真空除去溶剂后，通过快速色谱(乙酸乙酯/甲醇3∶1)分离粗制二氢吗啡酮，得到一棕色固体(1.21g，56％)，进而将其用乙醇(25ml)重结晶纯化，得到>98％纯净二氢吗啡酮(0.75g，35％)。1H NMR(CDCl3-CD3OD～10∶1)：δ1.25(qd，J＝4.5Hz和13.0Hz，1H)；1.79(ddd，J＝1.8，3.4和12.3Hz，1H)；1.88(dq，J＝4.1和13.0Hz，1H)；2.09(td，J＝4.7Hz和12.3Hz，1H)；2.25(td，J＝3.5Hz和12.1Hz，1H)；2.35(dd，J＝5.6Hz和18.6Hz，1H)；2.38-2.53(m，2H)；2.44(s，3H)；2.55-2.64(m，2H)；3.03(d，J＝18.6Hz，1H)；3.19(dd，J＝2.7和5.6Hz，1H)；4.67(s，1H)；6.61(d，J＝8.1Hz，1H)；6.70(d，J＝8.1Hz，1H).13C NMR(d6-DMSO)：δ19.5；25.0；34.8；39.6；41.4；42.5；46.2；46.3；58.3；90.3；116.9；119.1；124.4；127.3；139.2；143.9；208.6.

Claims (9)

1.制备式(I)化合物的新方法：
Figure C9719833800021
其中R1代表氢，甲基或通常用于保护酚或醇的保护基；R2代表氢，甲基，烯丙基，环丁基甲基，苄基，三烷基甲硅烷基或氨基保护基；R3代表氢，羟基或氨基；
该方法包括使式(II)化合物：
其中R1，R2和R3的定义同上，
与式(III)有机金属配合物反应：
Figure C9719833800023
其中M代表铑、钯、铂、铱或铁；Ar各自代表芳基，n代表2-5，X代表BF4 -或ClO4 -，且solv代表甲醇，二氯甲烷/甲醇，四氢呋喃，丙酮或乙醇。
2.根据权利要求1的方法，其中R1代表氢或甲基。
3.根据权利要求1或2的方法，其中R2代表氢或甲基。
4.根据权利要求3的方法，其中R2代表氢。
5.根据权利要求1或2的方法，其中R3代表氢。
6.根据权利要求1或2的方法，其中M代表铑。
7.根据权利要求1或2的方法，其中Ar代表苯基。
8.根据权利要求1或2的方法，其中n代表4。
9.根据权利要求1的方法，其中R1是氢或甲基，R2是氢，R3是氢，M是铑，Ar是苯基和n是4。
CN97198338A 1996-08-01 1997-07-18 麻醉性镇痛剂的制备 Expired - Lifetime CN1105721C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9616253.2A GB9616253D0 (en) 1996-08-01 1996-08-01 Preparation of narcotic analgesics
GB9616253.2 1996-08-01

Publications (2)

Publication Number Publication Date
CN1231667A CN1231667A (zh) 1999-10-13
CN1105721C true CN1105721C (zh) 2003-04-16

Family

ID=10797912

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97198338A Expired - Lifetime CN1105721C (zh) 1996-08-01 1997-07-18 麻醉性镇痛剂的制备

Country Status (15)

Country Link
US (1) US5847142A (zh)
EP (1) EP0915884B1 (zh)
JP (2) JP4316674B2 (zh)
CN (1) CN1105721C (zh)
AT (1) ATE215955T1 (zh)
AU (1) AU3629197A (zh)
DE (1) DE69711883T2 (zh)
DK (1) DK0915884T3 (zh)
ES (1) ES2175438T3 (zh)
GB (1) GB9616253D0 (zh)
MY (1) MY117858A (zh)
PL (1) PL186307B1 (zh)
TW (1) TW396157B (zh)
WO (1) WO1998005667A1 (zh)
ZA (1) ZA976853B (zh)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616253D0 (en) * 1996-08-01 1996-09-11 Johnson Matthey Plc Preparation of narcotic analgesics
CA2854796A1 (en) * 1999-11-09 2001-05-17 Purdue Pharma Hydromorphinone and hydrocodeinone compositions and methods for their synthesis
EP1506174B1 (en) * 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
JP2007528837A (ja) * 2002-11-11 2007-10-18 マリンクロッド・インコーポレイテッド ヒドロコドンおよびヒドロモルフォンの触媒的製造方法
US7323565B2 (en) * 2002-11-11 2008-01-29 Mallinckrodt Inc. Method for the catalytic production of hydrocodone and hydromorphone
US7321038B2 (en) * 2002-11-11 2008-01-22 Mallinckrodt Inc. Method for the catalytic production of hydrocodone and hydromorphone
US7399858B2 (en) * 2002-11-11 2008-07-15 Mallinckrodt Inc. Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
SK286047B6 (sk) * 2004-04-13 2008-01-07 Zentiva, A. S. Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
CN1914210A (zh) * 2004-05-13 2007-02-14 马林克罗特公司 用于催化生产氢可酮和氢吗啡酮的方法
US6946556B1 (en) 2004-05-21 2005-09-20 Acura Pharmaceuticals, Inc. Preparation of opioid analgesics by a one-pot process
US7348430B2 (en) * 2005-01-21 2008-03-25 Acura Pharmaceuticals, Inc. Production of opioid analgesics
EP1871774A1 (en) 2005-03-28 2008-01-02 Mallinckrodt, Inc. Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
AU2006259780B2 (en) * 2005-06-16 2012-04-12 SpecGx LLC A synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
US7399859B1 (en) 2007-02-06 2008-07-15 Cody Laboratories Inc. Method for catalytic preparation of hydromorphone and hydrocodone
ES2407033T3 (es) 2007-05-04 2013-06-11 Mallinckrodt Llc Procedimientos mejorados para la preparación de opiáceos 6-alfa-hidroxi-n-alquilados
US8962841B2 (en) 2007-06-29 2015-02-24 Brock University Methods for one-pot N-demethylation/N-functionalization of morphine and tropane alkaloids
US7999104B2 (en) 2007-06-29 2011-08-16 Brock University Methods for one-pot N-demethylation/N-acylation of morphine and tropane alkaloids
NZ582668A (en) * 2007-07-17 2012-02-24 Mallinckrodt Llc Preparation of n-alkylated opiates by reductive amination
CA2738628C (en) 2008-09-30 2017-07-04 Mallinckrodt Inc. Processes for the selective amination of ketomorphinans
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
WO2010118275A1 (en) * 2009-04-09 2010-10-14 Mallinckrodt Inc. Preparation of saturated ketone morphinan compounds
EP2417139B1 (en) * 2009-04-09 2016-03-23 Mallinckrodt LLC Preparation of saturated ketone morphinan compounds by catalytic isomerization
WO2010118274A1 (en) * 2009-04-09 2010-10-14 Mallinckrodt Inc. Preparation of 6-keto, 3-alkoxy morphinans
EP2440561B1 (en) * 2009-06-11 2014-04-30 Mallinckrodt LLC Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
WO2010144641A1 (en) * 2009-06-11 2010-12-16 Mallinckrodt Inc. Preparation of 6-alpha-amino n-substituted morphinans by catalytic hydrogen transfer
RS58894B1 (sr) 2009-12-04 2019-08-30 Alkermes Pharma Ireland Ltd Derivati morfinana za lečenje predoziranja lekom
ES2645725T3 (es) 2010-06-11 2017-12-07 Rhodes Technologies Procesos catalizados por metales de transición para la preparación de compuestos de N-alilo y uso de los mismos
EP2580218B1 (en) 2010-06-11 2015-02-25 Rhodes Technologies Process for n-dealkylation of tertiary amines
CA2804101C (en) * 2010-07-02 2021-01-19 Johnson Matthey Public Limited Company Process for the synthesis and purification of oxycodone
WO2012005795A1 (en) * 2010-07-08 2012-01-12 Alkermes, Inc. Process for the synthesis of substituted morphinans
HUE041981T2 (hu) 2010-08-23 2019-06-28 Alkermes Pharma Ireland Ltd Eljárások antipszichotikum által kiváltott súlygyarapodás kezelésére
BR112013028467A2 (pt) 2011-05-06 2016-08-16 Univ Brock processo para a preparação de análogos de morfina através da n-demetilação/funcionalização catalisada por metal e transferência de grupo intramolecular
MX2013013634A (es) 2011-06-09 2013-12-12 Mallinckrodt Llc Aminacion reductiva de 6-ceto-morfinanos por transfrencia catalitica de hidrogeno.
ES2566620T3 (es) 2011-09-08 2016-04-14 Mallinckrodt Llc Procesamiento de alcaloides sin el aislamiento de intermedios
US9211293B2 (en) 2011-12-15 2015-12-15 Alkermes Pharma Ireland Limited Opioid agonist antagonist combinations
US9656961B2 (en) 2013-05-24 2017-05-23 Alkermes Pharma Ireland Limited Methods for treating depressive symptoms
AU2014268361B2 (en) 2013-05-24 2018-09-06 Alkermes Pharma Ireland Limited Morphan and morphinan analogues, and methods of use
GB201313211D0 (en) 2013-07-24 2013-09-04 Cambrex Karlskoga Ab New process
EP3255051A1 (en) 2016-06-09 2017-12-13 Siegfried AG Supported metal catalyst for the production of hydrocodon and hydromorphon
US10081636B2 (en) 2016-07-08 2018-09-25 Cody Laboratories, Inc. Method for catalytic preparation of hydromorphone, hydrocodone, and other opiates
WO2022101444A1 (en) 2020-11-12 2022-05-19 Alkermes Pharma Ireland Limited Immediate release multilayer tablet
WO2022101408A1 (en) 2020-11-13 2022-05-19 Ferrer Internacional, S.A. Synthesis of hydromorphone base

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628962A (en) * 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2654756A (en) * 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2715626A (en) * 1950-07-05 1955-08-16 Merck & Co Inc Process of preparing dihydrocodeinone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1290174A (fr) * 1961-01-25 1962-04-13 S E M P A Chemie Préparation de la codéïnone à partir de la thébaïne
GB9616253D0 (en) * 1996-08-01 1996-09-11 Johnson Matthey Plc Preparation of narcotic analgesics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628962A (en) * 1949-10-20 1953-02-17 Mallinckrodt Chemical Works Method for preparing dihydrocodeinone, dihydromorphinone, and codeinone
US2654756A (en) * 1949-10-20 1953-10-06 Mallinckrodt Chemical Works Process of preparing codeinone, dihydrocodeinone, and dihydromorphinone
US2715626A (en) * 1950-07-05 1955-08-16 Merck & Co Inc Process of preparing dihydrocodeinone

Also Published As

Publication number Publication date
MY117858A (en) 2004-08-30
DK0915884T3 (da) 2002-07-01
PL186307B1 (pl) 2003-12-31
TW396157B (en) 2000-07-01
GB9616253D0 (en) 1996-09-11
ES2175438T3 (es) 2002-11-16
JP4316674B2 (ja) 2009-08-19
ATE215955T1 (de) 2002-04-15
JP2001500846A (ja) 2001-01-23
EP0915884B1 (en) 2002-04-10
JP2009161557A (ja) 2009-07-23
PL331525A1 (en) 1999-07-19
AU3629197A (en) 1998-02-25
DE69711883D1 (de) 2002-05-16
EP0915884A1 (en) 1999-05-19
WO1998005667A1 (en) 1998-02-12
CN1231667A (zh) 1999-10-13
US5847142A (en) 1998-12-08
ZA976853B (en) 1998-02-11
DE69711883T2 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
CN1105721C (zh) 麻醉性镇痛剂的制备
MX2008013842A (es) Proceso mejorado para la preparacion de opiatos 6-alfa-hidroxi-n-alquilados.
HUE034668T2 (hu) Eljárás morfinán-származékok szintézisére és azok intermedierjei
JPH0368022B2 (zh)
CN110183450B (zh) 一种2-芳基吲唑并马来酰亚胺类稠合多环化合物的合成方法
AU2003290629B2 (en) Method for the catalytic production of hydrocodone and hydromorphone
CN101775035A (zh) 一类氨基酸型两性水溶性手性膦配体的合成及其在不对称催化氢化中的应用
CN101638387A (zh) 由1,2,3,4-四氢异喹啉制备六氢异喹啉的方法
Trifonova et al. Variability of Rhodium (III)-Catalyzed Reactions of Aromatic Oximes with Alkenes
US6476250B1 (en) Optically active fluorinated binaphthol derivative
EP4163271A1 (en) Method for preparing methyl (s)-2-amino-3-(4-(2,3-dimethylpyridin-4-yl)phenylpropionate and salt thereof
CN111039767B (zh) 一种三唑卡宾催化制备氘代醛的方法
CN107827916B (zh) 一种(r)-(1-氨基-3-甲基)丁基-1-硼酸蒎烷二醇酯的合成方法
CN101279986B (zh) 一种非对称轴手性双膦配体合成方法
JP3440305B2 (ja) ７−（ｎ−置換アミノ）−２−フェニルヘプタン酸 エステル誘導体及び該誘導体の製造方法
CN115894365B (zh) 一种四氢异喹啉类化合物及其中间体的合成方法
CN111777553B (zh) 一种异喹啉类化合物的制备方法
JP2001513805A (ja) ６，６’−ビス−（１−ホスファノルボルナジエン）ジホスフィン
CA2261675C (en) Preparation of narcotic analgesics
JP2001026580A (ja) 光学活性１−アリール−１，２，３，４−テトラヒドロイソキノリン類の製造法
CN116003449A (zh) 一种具有c-b键的四氢喹啉类化合物的合成方法
CN114394933B (zh) 11,12-二氢-γ-氧代-二苯并[f]偶氮-5-(6h)-丁酸的合成方法
CN112028800B (zh) 半胱氨酸衍生物及其合成方法
CN113321600B (zh) 制备手性联芳基取代的4-氨基-丁酸及其衍生物的方法
CN113735826B (zh) 一种3-亚苄基-2，3-二氢喹诺酮化合物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20030416